| |||||||||||||||||||||||||||||||||||
|
As of July, people affiliated with the health sector and political action committees (PACs) associated with the sector had contributed about $29 million to presidential candidates, including $8.8 million to Obama, $6.6 million to Senator Hillary Clinton of New York, the former Democratic contender, and $4.7 million to McCain, according to the Center for Responsive Politics (www.opensecrets.org), a nonpartisan organization that researches money in politics. Although these contributions represent less than 3% of the funds raised by presidential candidates, it is remarkable that the health sector has reversed a long-standing pattern of favoring Republican candidates, by contributing substantially more money to Democrats ($17.7 million) than to Republicans ($11.2 million). This trend also holds when the presidential and congressional elections are considered together (see Figure 1): as of July, the health sector had contributed $54.5 million to Democrats and $46.1 million to Republicans. Democrats lead Republicans in contributions from health professionals and from individuals associated with hospitals, nursing homes, or health services or health maintenance organizations. Contributions linked to manufacturers of pharmaceutical and health care products are split about evenly between the parties. The last time Democrats raised more money from health care interests than Republicans was 1992, when Bill Clinton was elected president.
|
For federal elections, the major source of campaign funds is individuals (see Figure 1). Under the Bipartisan Campaign Reform Act, the contribution limit for an individual is $2,300 per candidate per election; primary and general elections are considered separate elections. Although businesses, labor unions, and ideological groups are prohibited from making direct contributions or expenditures in federal elections, they can establish PACs, which can receive up to $5,000 from an individual per calendar year and can contribute up to $5,000 per candidate per election.
The Center for Responsive Politics analyzes campaign finance data reported to the Federal Election Commission and classifies contributions of $200 or more from individual donors and their immediate families, as well as from PACs, into 13 sectors. As of the end of July, the health sector ranked sixth among the 13 sectors in contributions to federal elections since January 2007. Health professionals, a grouping that includes doctors, dentists, and nurses, ranked fifth among more than 80 industries. Within the health sector, the largest contributors (individuals and PACs) were associated with the American Dental Association ($1.7 million, 52% to Democrats), the American Hospital Association ($1.5 million, 61% to Democrats), Pfizer ($1.1 million, 50% to Democrats), the American Society of Anesthesiologists ($1.0 million, 47% to Democrats), and Amgen ($1.0 million, 50% to Democrats).
As of the end of July, Obama had received $5.4 million from health professionals, $1.6 million from individuals and PACs associated with hospitals and nursing homes, and $0.9 million from individuals and PACs associated with the pharmaceutical and health products industries, as compared with contributions to McCain of $3.2 million, $0.5 million, and $0.4 million, respectively. For the general election, McCain will receive about $84 million in government funding and thus cannot raise or spend private funds after accepting the Republican nomination. Because Obama is not taking public money, he can continue to raise and spend private funds. Obama's fund-raising lead from the health sector can only continue to grow.
The national Democratic and Republican parties used to regularly solicit and accept "soft money" contributions. These donations were not meant to be used to support or oppose the election or defeat of federal candidates but for other programs, such as voter registration campaigns. Increasingly, however, soft money was used for activities, such as advertisements about specific issues and the candidates' positions, that were in fact intended to influence the outcome of federal elections. In the 2002 election cycle, the parties raised hundreds of millions of dollars in such unregulated contributions, including $19.3 million from manufacturers of pharmaceuticals and health products. After the 2002 election, the Bipartisan Campaign Reform Act banned such contributions. As a result, total contributions to federal campaigns that are linked to pharmaceutical and health product companies plummeted.
The health care industry spends substantially more money for purposes for which federal law does not restrict its spending, such as to finance the host committees at the Democratic and Republican national conventions and to lobby Congress and federal agencies. Although the conventions receive public funds, their host committees receive tens of millions of dollars in soft-money donations, primarily from large corporations and lobbying firms.4 In 2008, the Pharmaceutical Research and Manufacturers of America (PhRMA) as well as individual drug and medical-device companies were among the sponsors of the host committees at both national conventions and organized numerous convention-related events.5
Since 2006, the health sector has spent more money on lobbying than any other sector of the economy (see Figure 2). Updated statistics for 2006 show that the health sector spent $379.8 million to lobby the federal government, about $5 million more than the finance, insurance, and real estate sector and about $28 million more than was previously reported.1 In 2007, the health sector spent $450.7 million, nearly a 20% increase from the amount in 2006 and about $35 million more than was spent by the financial sector. Within the health sector, manufacturers of drugs, medical devices, and other health care products spend the most and have increased their spending more rapidly than other health care industries. In 2007, PhRMA spent $22.7 million, the American Medical Association $22.1 million, the American Hospital Association $19.7 million, Amgen $16.3 million, and Pfizer $13.8 million, ranking 3rd, 4th, 5th, 9th, and 15th, respectively, among the top spenders on lobbying.
|
Source Information
Dr. Steinbrook (rsteinbrook{at}attglobal.net) is a national correspondent for the Journal.
References
| |||||||||||||||||||||||||||||||||||
HOME | SUBSCRIBE | SEARCH | CURRENT ISSUE | PAST ISSUES | COLLECTIONS | PRIVACY | TERMS OF USE | HELP | beta.nejm.org Comments and questions? Please contact us. The New England Journal of Medicine is owned, published, and copyrighted © 2009 Massachusetts Medical Society. All rights reserved. |